Non-24-Hour Sleep-Wake Disorder Revisited - A Case Study
- PMID: 26973592
- PMCID: PMC4770037
- DOI: 10.3389/fneur.2016.00017
Non-24-Hour Sleep-Wake Disorder Revisited - A Case Study
Abstract
The human sleep-wake cycle is governed by two major factors: a homeostatic hourglass process (process S), which rises linearly during the day, and a circadian process C, which determines the timing of sleep in a ~24-h rhythm in accordance to the external light-dark (LD) cycle. While both individual processes are fairly well characterized, the exact nature of their interaction remains unclear. The circadian rhythm is generated by the suprachiasmatic nucleus ("master clock") of the anterior hypothalamus, through cell-autonomous feedback loops of DNA transcription and translation. While the phase length (tau) of the cycle is relatively stable and genetically determined, the phase of the clock is reset by external stimuli ("zeitgebers"), the most important being the LD cycle. Misalignments of the internal rhythm with the LD cycle can lead to various somatic complaints and to the development of circadian rhythm sleep disorders (CRSD). Non-24-hour sleep-wake disorders (N24HSWD) is a CRSD affecting up to 50% of totally blind patients and characterized by the inability to maintain a stable entrainment of the typically long circadian rhythm (tau > 24.5 h) to the LD cycle. The disease is rare in sighted individuals and the pathophysiology less well understood. Here, we present the case of a 40-year-old sighted male, who developed a misalignment of the internal clock with the external LD cycle following the treatment for Hodgkin's lymphoma (ABVD regimen, four cycles and AVD regimen, four cycles). A thorough clinical assessment, including actigraphy, melatonin profiles and polysomnography led to the diagnosis of non-24-hour sleep-wake disorders (N24HSWD) with a free-running rhythm of tau = 25.27 h. A therapeutic intervention with bright light therapy (30 min, 10,000 lux) in the morning and melatonin administration (0.5-0.75 mg) in the evening failed to entrain the free-running rhythm, although a longer treatment duration and more intense therapy might have been successful. The sudden onset and close timely connection led us to hypothesize that the chemotherapy might have caused a mutation of the molecular clock components leading to the observed elongation of the circadian period.
Keywords: Hodgkin’s lymphoma; bright light therapy; circadian rhythm sleep disorders; melatonin; non-24-hour sleep-wake disorder.
Figures
![Figure 1](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/4770037/bin/fneur-07-00017-g001.gif)
![Figure 2](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/4770037/bin/fneur-07-00017-g002.gif)
![Figure 3](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/4770037/bin/fneur-07-00017-g003.gif)
![Figure 4](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/4770037/bin/fneur-07-00017-g004.gif)
Similar articles
-
Diagnostic and Treatment Challenges of Sighted Non-24-Hour Sleep-Wake Disorder.J Clin Sleep Med. 2018 Apr 15;14(4):603-613. doi: 10.5664/jcsm.7054. J Clin Sleep Med. 2018. PMID: 29609703 Free PMC article.
-
Circadian rhythm sleep disorders: pathophysiology and potential approaches to management.CNS Drugs. 2001;15(4):311-28. doi: 10.2165/00023210-200115040-00005. CNS Drugs. 2001. PMID: 11463135 Review.
-
Advances in the pharmacological management of non-24-h sleep-wake disorder.Expert Opin Pharmacother. 2021 Jun;22(8):1039-1049. doi: 10.1080/14656566.2021.1876665. Epub 2021 Feb 23. Expert Opin Pharmacother. 2021. PMID: 33618599
-
Circadian Rhythm Disturbances in the Blind.Curr Neurol Neurosci Rep. 2018 Aug 6;18(10):65. doi: 10.1007/s11910-018-0876-9. Curr Neurol Neurosci Rep. 2018. PMID: 30083814 Review.
-
[Diagnosis and comorbidities of Circadian Rhythm Sleep Disorders].Presse Med. 2018 Nov-Dec;47(11-12 Pt 1):969-976. doi: 10.1016/j.lpm.2018.10.016. Epub 2018 Nov 1. Presse Med. 2018. PMID: 30391268 Review. French.
Cited by
-
Sleep deprivation therapy to reset the circadian pacemaker in a non-24-hour sleep-wake disorder: a case report.J Clin Sleep Med. 2021 Jul 1;17(7):1503-1506. doi: 10.5664/jcsm.9294. J Clin Sleep Med. 2021. PMID: 33792535 Free PMC article.
-
Workshop report. Circadian rhythm sleep-wake disorders: gaps and opportunities.Sleep. 2021 May 14;44(5):zsaa281. doi: 10.1093/sleep/zsaa281. Sleep. 2021. PMID: 33582815 Free PMC article.
-
Non-24-hour sleep-wake disorder successfully treated with the combination of ramelteon and suvorexant in a case of autism spectrum disorder.Neuropsychopharmacol Rep. 2020 Dec;40(4):383-387. doi: 10.1002/npr2.12142. Epub 2020 Sep 29. Neuropsychopharmacol Rep. 2020. PMID: 32990413 Free PMC article.
-
Diagnostic and Treatment Challenges of Sighted Non-24-Hour Sleep-Wake Disorder.J Clin Sleep Med. 2018 Apr 15;14(4):603-613. doi: 10.5664/jcsm.7054. J Clin Sleep Med. 2018. PMID: 29609703 Free PMC article.
-
Non-24-Hour Sleep-Wake Rhythm Disorder and Melatonin Secretion Impairment in a Patient With Pineal Cyst.J Clin Sleep Med. 2017 Nov 15;13(11):1355-1357. doi: 10.5664/jcsm.6816. J Clin Sleep Med. 2017. PMID: 28992833 Free PMC article.
References
-
- Johns MW. A new method for measuring daytime sleepiness: the Epworth sleepiness Scale. Sleep (1991) 14:50–5. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials